SEARCH

SEARCH BY CITATION

References

  • 1
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197207.
  • 2
    Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H 2002 Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915921.
  • 3
    Sainsbury A, Schwarzer C, Couzens M, Herzog H 2002 Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51:34203427.
  • 4
    Naveilhan P, Svensson L, Nystrom S, Ekstrand AJ, Ernfors P 2002 Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides 23:10871091.
  • 5
    Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR 1993 Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132:19391944.
  • 6
    Sainsbury A, Baldock PA, Schwarzer C, Ueno N, Enriquez RF, Couzens M, Inui A, Herzog H, Gardiner EM 2003 Synergistic reduction in adiposity and increase in bone mass in Y2/Y4 receptor double knockout mice. Mol Cell Biol 23:52255233.
  • 7
    Elefteriou F, Takeda S, Liu X, Armstrong D, Karsenty G 2003 Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. Endocrinology 144:38423847.
  • 8
    Erickson JC, Clegg KE, Palmiter RD 1996 Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415421.
  • 9
    Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF 1986 Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:11891192.
  • 10
    Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:17041707.
  • 11
    Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543546.
  • 12
    Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ 2003 Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18:20872092.
  • 13
    Stanley BG, Leibowitz SF 1984 Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:26352642.
  • 14
    Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF 1986 Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:11891192.
  • 15
    Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H 2002 Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 99:89388943.
  • 16
    Melsen F, Mosekilde L 1980 Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions. Acta Pathol Microbiol Scand 88:8388. [A].
  • 17
    Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530532.
  • 18
    King PJ, Williams G, Doods H, Widdowson PS 2000 Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release. Eur J Pharmacol 396:R1R3.
  • 19
    Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS 1995 Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1:13111314.
  • 20
    Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G 2004 Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101:32583263.
  • 21
    Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van Der Ploeg LH, Marsh DJ 2002 Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22:50275035.
  • 22
    Herzog H 2002 Hypothalamic Y2 receptors: Central coordination of energy homeostasis and bone mass regulation. Drug News Perspect 15:506510.